Market capitalization | JPY185.07b |
Enterprise Value | JPY168.61b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.25 |
P/S ratio (TTM) P/S ratio | 1.38 |
P/B ratio (TTM) P/B ratio | 0.87 |
Dividend yield | 1.20% |
Last dividend (FY23) | JPY20.00 |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
4 Analysts have issued a DeNA forecast:
4 Analysts have issued a DeNA forecast:
Jun '24 |
+/-
%
|
||
Revenue | 134,565 134,565 |
1%
1%
|
|
Gross Profit | 60,061 60,061 |
6%
6%
|
|
EBITDA | 6,854 6,854 |
13%
13%
|
EBIT (Operating Income) EBIT | 546 546 |
77%
77%
|
Net Profit | -30,270 -30,270 |
577%
577%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DeNA Co., Ltd. engages in the development and operation of mobile and online services including games, e-commerce and entertainment content distribution. It operates through the following segments: Games, Electronic Commerce (EC), Sports, Automotive, Healthcare, and New Businesses and Others. The Games segment offers mobile games such as DeNA games, mobage, and AndApp. The EC segment provides e-commerce services such as Mobaoku. The Sports segment handles Yokohama DeNA Baystars, Yokohma DeNA Running Club, and Kawasaki Brave Thunders. The Automotive segment manages transportation applications such as MOV, Anyca, SOMPO DE NORU, Easy Ride, and Robot Shuttle. The Healthcare segment deals with digital healthcare services such as DeNa Healthcare, MYCODE, kencom, and Aruite Otoku. The New Businesses and Others segment includes products such as Strategic Investment Office and Delight Ventures. The company was founded by Tomoko Namba and Masayuki Watanabe on March 4, 1999 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Shingo Okamura |
Employees | 2,897 |
Founded | 1999 |
Website | www.dena.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.